FFAR4 and metabolic syndrome: After 20 weeks, we measured cardiac function by echocardiography in both male WT and Ffar4KO mice to determine if MetS induced HFpEF in WT mice and if loss of Ffar4 worsened cardiac function secondary to MetS (Fig. 2 and supplemental Table 3A).